A clinical overview of azelaic acid

Boni Elewski, Diane Thiboutot

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

Azelaic acid (AzA) initially was released in a 20% cream formulation, which has been shown to be effective in the treatment of mild to moderate rosacea. Recently, a 15% gel formulation was developed that vastly improved the delivery of AzA and has been proven by multiple studies to be effective in the treatment of rosacea. We present studies that examine both of these formulations, first in comparison with their vehicles and then in contrast with other well-accepted topical treatments of rosacea, such as metronidazole cream and gel.

Original languageEnglish (US)
Pages (from-to)12-16
Number of pages5
JournalCutis
Volume77
Issue number2 SUPPL.
StatePublished - Feb 1 2006

Fingerprint

Rosacea
Gels
Metronidazole
azelaic acid

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

Elewski, B., & Thiboutot, D. (2006). A clinical overview of azelaic acid. Cutis, 77(2 SUPPL.), 12-16.
Elewski, Boni ; Thiboutot, Diane. / A clinical overview of azelaic acid. In: Cutis. 2006 ; Vol. 77, No. 2 SUPPL. pp. 12-16.
@article{2c203920bb5d4d7281de136509c712e6,
title = "A clinical overview of azelaic acid",
abstract = "Azelaic acid (AzA) initially was released in a 20{\%} cream formulation, which has been shown to be effective in the treatment of mild to moderate rosacea. Recently, a 15{\%} gel formulation was developed that vastly improved the delivery of AzA and has been proven by multiple studies to be effective in the treatment of rosacea. We present studies that examine both of these formulations, first in comparison with their vehicles and then in contrast with other well-accepted topical treatments of rosacea, such as metronidazole cream and gel.",
author = "Boni Elewski and Diane Thiboutot",
year = "2006",
month = "2",
day = "1",
language = "English (US)",
volume = "77",
pages = "12--16",
journal = "Cutis",
issn = "0011-4162",
publisher = "Quadrant Healthcom Inc.",
number = "2 SUPPL.",

}

Elewski, B & Thiboutot, D 2006, 'A clinical overview of azelaic acid', Cutis, vol. 77, no. 2 SUPPL., pp. 12-16.

A clinical overview of azelaic acid. / Elewski, Boni; Thiboutot, Diane.

In: Cutis, Vol. 77, No. 2 SUPPL., 01.02.2006, p. 12-16.

Research output: Contribution to journalReview article

TY - JOUR

T1 - A clinical overview of azelaic acid

AU - Elewski, Boni

AU - Thiboutot, Diane

PY - 2006/2/1

Y1 - 2006/2/1

N2 - Azelaic acid (AzA) initially was released in a 20% cream formulation, which has been shown to be effective in the treatment of mild to moderate rosacea. Recently, a 15% gel formulation was developed that vastly improved the delivery of AzA and has been proven by multiple studies to be effective in the treatment of rosacea. We present studies that examine both of these formulations, first in comparison with their vehicles and then in contrast with other well-accepted topical treatments of rosacea, such as metronidazole cream and gel.

AB - Azelaic acid (AzA) initially was released in a 20% cream formulation, which has been shown to be effective in the treatment of mild to moderate rosacea. Recently, a 15% gel formulation was developed that vastly improved the delivery of AzA and has been proven by multiple studies to be effective in the treatment of rosacea. We present studies that examine both of these formulations, first in comparison with their vehicles and then in contrast with other well-accepted topical treatments of rosacea, such as metronidazole cream and gel.

UR - http://www.scopus.com/inward/record.url?scp=33645096952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645096952&partnerID=8YFLogxK

M3 - Review article

VL - 77

SP - 12

EP - 16

JO - Cutis

JF - Cutis

SN - 0011-4162

IS - 2 SUPPL.

ER -

Elewski B, Thiboutot D. A clinical overview of azelaic acid. Cutis. 2006 Feb 1;77(2 SUPPL.):12-16.